301290 东星医疗
已收盘 03-03 15:00:00
资讯
新帖
简况
东星医疗最新公告：股东江世华减持0.6079%股份
证券之星 · 03-02 18:29
东星医疗最新公告：股东江世华减持0.6079%股份
东星医疗4.36亿元商誉高悬 由盈转亏仍要现金收购|并购谈
新浪证券 · 02-28
东星医疗4.36亿元商誉高悬 由盈转亏仍要现金收购|并购谈
东星医疗（301290）披露筹划重大资产重组进展公告，2月26日股价上涨0.45%
证券之星 · 02-26
东星医疗（301290）披露筹划重大资产重组进展公告，2月26日股价上涨0.45%
东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）
证券之星 · 02-24
东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）
东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）
证券之星 · 02-12
东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）
东星医疗：截至2026年1月30日，公司股东总数为9,302名（含信用账户）
证券之星 · 02-05
东星医疗：截至2026年1月30日，公司股东总数为9,302名（含信用账户）
股市必读：东星医疗（301290）1月30日董秘有最新回复
证券之星 · 02-02
股市必读：东星医疗（301290）1月30日董秘有最新回复
东星医疗：拟以现金方式购买武汉医佳宝90%股权
证券之星 · 01-30
东星医疗：拟以现金方式购买武汉医佳宝90%股权
东星医疗：预计2025年全年归属净利润亏损3200万元至4500万元
证券之星 · 01-27
东星医疗：预计2025年全年归属净利润亏损3200万元至4500万元
东星医疗：截至2026年1月20日，公司股东总数为8,993名（含信用账户）
证券之星 · 01-26
东星医疗：截至2026年1月20日，公司股东总数为8,993名（含信用账户）
股市必读：东星医疗（301290）1月20日董秘有最新回复
证券之星 · 01-21
股市必读：东星医疗（301290）1月20日董秘有最新回复
东星医疗：公司目前尚未涉及手术机器人相关产品研发
证券之星 · 01-20
东星医疗：公司目前尚未涉及手术机器人相关产品研发
东星医疗：截至2026年1月9日股东总数为9,301名
证券之星 · 01-14
东星医疗：截至2026年1月9日股东总数为9,301名
东星医疗（301290）披露关于变更签字注册会计师的公告，1月12日股价上涨0.04%
证券之星 · 01-12
东星医疗（301290）披露关于变更签字注册会计师的公告，1月12日股价上涨0.04%
东星医疗（301290）披露2025年现场检查报告，1月9日股价上涨1.17%
证券之星 · 01-09
东星医疗（301290）披露2025年现场检查报告，1月9日股价上涨1.17%
股市必读：东星医疗(301290)股东户数0.92万户，较上期减少1.27%
证券之星 · 01-08
股市必读：东星医疗(301290)股东户数0.92万户，较上期减少1.27%
每周股票复盘：东星医疗（301290）股东江世华减持后持股比降至4.9999%
证券之星 · 01-03
每周股票复盘：东星医疗（301290）股东江世华减持后持股比降至4.9999%
12月30日东星医疗发布公告，股东减持6.14万股
证券之星 · 2025-12-30
12月30日东星医疗发布公告，股东减持6.14万股
东星医疗（301290）披露筹划重大资产重组进展公告，12月29日股价上涨0.63%
证券之星 · 2025-12-29
东星医疗（301290）披露筹划重大资产重组进展公告，12月29日股价上涨0.63%
东星医疗：截至2025年12月19日股东总数为9,304名
证券之星 · 2025-12-23
东星医疗：截至2025年12月19日股东总数为9,304名
加载更多
公司概况
公司名称：
江苏东星智慧医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2022-11-30
主营业务：
江苏东星智慧医疗科技股份有限公司的主营业务是以吻合器为代表的外科手术医疗器械的研发、生产和销售。公司的主要产品是腔镜吻合器、开放式吻合器、吻合器零部件、外科手术设备等。
发行价格：
44.09
{"stockData":{"symbol":"301290","market":"SZ","secType":"STK","nameCN":"东星医疗","latestPrice":27.25,"timestamp":1772521428000,"preClose":28,"halted":0,"volume":1776100,"delay":0,"changeRate":-0.0268,"floatShares":68163400,"shares":100000000,"eps":-0.2132,"marketStatus":"已收盘","change":-0.75,"latestTime":"03-03 15:00:00","open":28.04,"high":28.3,"low":27.25,"amount":49192500,"amplitude":0.0375,"askPrice":27.32,"askSize":20,"bidPrice":27.25,"bidSize":59,"shortable":0,"etf":0,"ttmEps":-0.2132,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772587800000},"marketStatusCode":5,"adr":0,"adjPreClose":28,"symbolType":"stock","openAndCloseTimeList":[[1772501400000,1772508600000],[1772514000000,1772521200000]],"highLimit":30.8,"lowLimit":25.2,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":100173334,"isCdr":false,"pbRate":1.32,"roa":"--","roe":"--","epsLYR":0.98,"committee":-0.07,"marketValue":2730000000,"turnoverRate":0.0261,"status":1,"floatMarketCap":1857000000},"requestUrl":"/m/hq/s/301290","defaultTab":"news","newsList":[{"id":"2616633333","title":"东星医疗最新公告：股东江世华减持0.6079%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616633333","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616633333?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:29","pubTimestamp":1772447389,"startTime":"0","endTime":"0","summary":"东星医疗(301290.SZ)公告称，持股5%以上股东江世华于2025年12月29日至2026年2月28日期间，通过集中竞价交易方式累计减持公司股份609,000股，占公司总股本的0.6079%；减持原因为个人资金需求，股份来源为公司首次公开发行前已发行的股份；本次减持计划期限届满，剩余未实施部分自动作废。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200029269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2614289000","title":"东星医疗4.36亿元商誉高悬 由盈转亏仍要现金收购|并购谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2614289000","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614289000?lang=zh_cn&edition=full","pubTime":"2026-02-28 15:18","pubTimestamp":1772263080,"startTime":"0","endTime":"0","summary":"2026年2月26日，东星医疗发布了《关于筹划重大资产重组的进展公告》，将这起筹划的收购案再次拉回公众视野，公司拟以支付现金的方式收购武汉医佳宝90%的股权。2017年，东星医疗以近4亿元收购威克医疗，形成3.07亿元商誉，增值率高达1283.85%；2019年，又以近4亿元收购孜航精密，再添2.24亿元商誉。 4.36亿元商誉的风险在于，一旦此次跨界收购整合不力，或者任一子公司业绩进一步恶化，商誉减值损失将吞噬盈利，让亏损的公司更难。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-02-28/doc-inhpkaqh6008488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2614023980","title":"东星医疗（301290）披露筹划重大资产重组进展公告，2月26日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614023980","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614023980?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:51","pubTimestamp":1772117473,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，东星医疗报收于29.22元，较前一交易日上涨0.45%，最新总市值为29.27亿元。该股当日开盘29.14元，最高29.49元，最低29.02元，成交额达4140.09万元，换手率为2.08%。公司于近日披露《关于筹划重大资产重组的进展公告》。本次交易预计构成重大资产重组，不涉及发行股份，不构成关联交易，不会导致公司控股股东和实际控制人变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2613564760","title":"东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）","url":"https://stock-news.laohu8.com/highlight/detail?id=2613564760","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613564760?lang=zh_cn&edition=full","pubTime":"2026-02-24 15:27","pubTimestamp":1771918025,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)02月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到2026年2月10日股东人数多少？谢谢东星医疗回复：尊敬的投资者，您好！截至2026年2月10日，公司股东总数为9,462名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400023062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2610992809","title":"东星医疗：截至2026年2月10日，公司股东总数为9,462名（含信用账户）","url":"https://stock-news.laohu8.com/highlight/detail?id=2610992809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610992809?lang=zh_cn&edition=full","pubTime":"2026-02-12 11:36","pubTimestamp":1770867362,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年二月 10日公司的股东总数是多少？谢谢东星医疗回复：尊敬的投资者，您好！截至2026年2月10日，公司股东总数为9,462名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200014560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2609326649","title":"东星医疗：截至2026年1月30日，公司股东总数为9,302名（含信用账户）","url":"https://stock-news.laohu8.com/highlight/detail?id=2609326649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609326649?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:06","pubTimestamp":1770275177,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)02月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年一月 30日公司的股东总数是多少？谢谢东星医疗回复：尊敬的投资者，您好！截至2026年1月30日，公司股东总数为9,302名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500018917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2608881567","title":"股市必读：东星医疗（301290）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608881567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608881567?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:19","pubTimestamp":1769977149,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，东星医疗报收于28.96元，上涨2.01%，换手率2.09%，成交量1.42万手，成交额4090.78万元。公司积极组织各中介机构开展对标的公司的尽职调查以及审计、评估等工作，并就上述重大资产重组事项同各相关方持续沟通协商。因财务数据有效期要求，公司及标的公司目前正有序组织相关方对本次交易涉及的财务数据进行加期审计及更新工作，后续公司亦将按照相关法律法规的规定及时披露项目进展情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2607704804","title":"东星医疗：拟以现金方式购买武汉医佳宝90%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704804?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:52","pubTimestamp":1769777551,"startTime":"0","endTime":"0","summary":"公司与武汉医佳宝全体股东签署《股权收购意向协议》，拟通过支付现金方式购买武汉医佳宝90%的股权，本次交易如能顺利实施，武汉医佳宝将成为公司的控股子公司。因财务数据有效期要求，公司及标的公司目前正有序组织相关方对本次交易涉及的财务数据进行加期审计及更新工作，后续公司亦将按照相关法律法规的规定及时披露项目进展情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000043668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2606200633","title":"东星医疗：预计2025年全年归属净利润亏损3200万元至4500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606200633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606200633?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:03","pubTimestamp":1769508206,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗发布业绩预告，预计2025年全年归属净利润亏损3200万元至4500万元。东星医疗2025年三季报显示，前三季度公司主营收入2.84亿元，同比下降10.21%；归母净利润-5320.16万元，同比下降181.13%；扣非净利润-6961.86万元，同比下降263.18%；其中2025年第三季度，公司单季度主营收入1.0亿元，同比下降1.97%；单季度归母净利润-8349.45万元，同比下降566.49%；单季度扣非净利润-8865.51万元，同比下降834.63%；负债率10.77%，投资收益1889.36万元，财务费用49.96万元，毛利率48.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700031150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290"],"gpt_icon":0},{"id":"2606941382","title":"东星医疗：截至2026年1月20日，公司股东总数为8,993名（含信用账户）","url":"https://stock-news.laohu8.com/highlight/detail?id=2606941382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606941382?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:04","pubTimestamp":1769411071,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止到一月二十日股东人数是多少？东星医疗回复：尊敬的投资者，您好！截至2026年1月20日，公司股东总数为8,993名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600014190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2605145654","title":"股市必读：东星医疗（301290）1月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605145654?lang=zh_cn&edition=full","pubTime":"2026-01-21 03:08","pubTimestamp":1768936092,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，东星医疗报收于28.84元，下跌0.69%，换手率2.08%，成交量1.41万手，成交额4085.03万元。董秘最新回复投资者： 公司作为吻合器领先企业，是否有布局手术机器人甚至智能手术机器人赛道？公司目前尚未涉及手术机器人相关方面产品的设计、研发或生产。目前公司研发重点主要为行业前瞻性的电动腔镜吻合器、超声刀、组织夹等产品。当日关注点来自交易信息汇总：1月20日主力资金净流出314.92万元，散户资金净流入468.18万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100001318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2604410113","title":"东星医疗：公司目前尚未涉及手术机器人相关产品研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2604410113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604410113?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:52","pubTimestamp":1768913575,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗01月20日在投资者关系平台上答复投资者关心的问题。公司目前尚未涉及手术机器人相关方面产品的设计、研发或生产。目前公司研发重点主要为行业前瞻性的电动腔镜吻合器、超声刀、组织夹等产品。感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000037421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2603709651","title":"东星医疗：截至2026年1月9日股东总数为9,301名","url":"https://stock-news.laohu8.com/highlight/detail?id=2603709651","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603709651?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:39","pubTimestamp":1768351147,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年一月 9日公司的股东总数是多少？谢谢东星医疗回复：尊敬的投资者，您好！截至2026年1月9日，公司股东总数为9,301名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400006593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2602549813","title":"东星医疗（301290）披露关于变更签字注册会计师的公告，1月12日股价上涨0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602549813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602549813?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:41","pubTimestamp":1768228871,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，东星医疗报收于26.85元，较前一交易日上涨0.04%，最新总市值为26.9亿元。公司近日发布公告称，江苏东星智慧医疗科技股份有限公司于2025年4月14日续聘立信会计师事务所为公司2025年度财务报告及内部控制审计机构。原签字注册会计师朱磊和尚净宇变更为朱磊和张宇。张宇自2024年起成为注册会计师，2024年开始在立信执业，2025年开始为公司提供审计服务，近三年未因执业行为受到处罚。本次变更不影响公司审计工作的正常进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2602372371","title":"东星医疗（301290）披露2025年现场检查报告，1月9日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372371","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602372371?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:48","pubTimestamp":1767970090,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，东星医疗报收于26.84元，较前一交易日上涨1.17%，最新总市值为26.89亿元。该股当日开盘26.38元，最高26.92元，最低26.11元，成交额达4011.71万元，换手率为2.2%。近日，华泰联合证券有限责任公司发布了关于江苏东星智慧医疗科技股份有限公司2025年现场检查报告。公告显示，华泰联合证券于2025年12月30日对东星医疗开展了2025年度现场检查。保荐人已督促公司及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900041362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2601492383","title":"股市必读：东星医疗(301290)股东户数0.92万户，较上期减少1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601492383","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601492383?lang=zh_cn&edition=full","pubTime":"2026-01-08 02:45","pubTimestamp":1767811512,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，东星医疗报收于26.16元，上涨0.11%，换手率1.42%，成交量9706.0手，成交额2526.38万元。交易信息汇总资金流向1月7日主力资金净流出228.92万元；游资资金净流入360.42万元；散户资金净流出131.5万元。股本股东变化股东户数变动近日东星医疗披露，截至2025年12月31日公司股东户数为9186.0户，较12月19日减少118.0户，减幅为1.27%。户均持股数量由上期的1.08万股增加至1.09万股，户均持股市值为27.56万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800001311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2600985850","title":"每周股票复盘：东星医疗（301290）股东江世华减持后持股比降至4.9999%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600985850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600985850?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:24","pubTimestamp":1767385451,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，东星医疗报收于25.27元，较上周的25.28元下跌0.04%。本次减持后，其持股比例由5.0612%下降至4.9999%，不再为持股5%以上股东。减持后持股数量为5,008,600股，持股比例降至4.9999%。江世华已质押股份3,500,000股，占公司总股本的3.4939%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2595079492","title":"12月30日东星医疗发布公告，股东减持6.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595079492","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595079492?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:02","pubTimestamp":1767096133,"startTime":"0","endTime":"0","summary":"证券之星消息，12月30日东星医疗发布公告《东星医疗:关于持股5%以上股份的股东持股比例变动触及1%及5%整数倍暨披露简式权益变动报告书的提示性公告》，其股东江世华于2025年12月29日合计减持6.14万股，占公司目前总股本的0.0613%，变动期间该股股价上涨0.63%，截止12月29日收盘报25.44元。股东增减持详情见下表：根据东星医疗2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000038347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301290"],"gpt_icon":0},{"id":"2595869789","title":"东星医疗（301290）披露筹划重大资产重组进展公告，12月29日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595869789","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595869789?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:49","pubTimestamp":1767001754,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，东星医疗报收于25.44元，较前一交易日上涨0.63%，最新总市值为25.48亿元。公司近日发布公告称，江苏东星智慧医疗科技股份有限公司拟以支付现金方式购买武汉医佳宝生物材料有限公司90%的股权。本次交易预计构成重大资产重组，不涉及发行股份，不构成关联交易，不会导致公司控股股东和实际控制人变更。公司已发布多次进展公告，并将持续履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900024613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0},{"id":"2593464003","title":"东星医疗：截至2025年12月19日股东总数为9,304名","url":"https://stock-news.laohu8.com/highlight/detail?id=2593464003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593464003?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:04","pubTimestamp":1766473472,"startTime":"0","endTime":"0","summary":"证券之星消息，东星医疗(301290)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截至2025年12月19日，公司股东人数是多少？东星医疗回复：尊敬的投资者，您好！截至2025年12月19日，公司股东总数为9,304名（含信用账户）。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301290","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772538240354,"stockEarnings":[{"period":"1week","weight":-0.0515},{"period":"1month","weight":-0.0331},{"period":"3month","weight":0.065},{"period":"6month","weight":0.0332},{"period":"1year","weight":0.234},{"period":"ytd","weight":0.108}],"compareEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.0157},{"period":"3month","weight":0.0731},{"period":"6month","weight":0.0968},{"period":"1year","weight":0.2595},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏东星智慧医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9575人(较上一季度增加1.19%)","perCapita":"7118股","listingDate":"2022-11-30","address":"江苏省常州市武进区长扬路24-4号","registeredCapital":"10017万元","survey":" 江苏东星智慧医疗科技股份有限公司的主营业务是以吻合器为代表的外科手术医疗器械的研发、生产和销售。公司的主要产品是腔镜吻合器、开放式吻合器、吻合器零部件、外科手术设备等。","listedPrice":44.09},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东星医疗(301290)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东星医疗(301290)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东星医疗,301290,东星医疗股票,东星医疗股票老虎,东星医疗股票老虎国际,东星医疗行情,东星医疗股票行情,东星医疗股价,东星医疗股市,东星医疗股票价格,东星医疗股票交易,东星医疗股票购买,东星医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东星医疗(301290)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东星医疗(301290)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}